NAVIGANTIS, founded in 2022, is pioneering advancements in the field of Neurovascular Robotics. Situated at the intersection of the Health Care, Health and Wellness, and Robotics industries, the company is headquartered in the United States. It aims to empower physicians by providing cutting-edge tools that enhance neurovascular care, pushing the boundaries of what surgical robotics can achieve.
Recently, NAVIGANTIS secured a $12.00M Series A investment as of July 25, 2024. The investment was led by notable investors such as Cormorant Asset Management, Mirae Asset Capital, and Puma Venture Capital. This infusion of capital highlights the growing confidence in NAVIGANTIS's potential to become a leader within its niche. The company is well-placed to revolutionize surgical procedures with its innovative approach, making it a promising addition for venture capitalists seeking impactful investments in med-tech innovation.